04/25/2024
4:20 PM | Voyager Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
4:20 PM | Voyager Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024
4:22 PM | Voyager Therapeutics (Filer)
| Form ARS | |
04/02/2024
2:24 PM | Sandrock Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
2:29 PM | Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024
4:24 PM | Ferguson Toby (Reporting)
Voyager Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/26/2024
4:27 PM | Ferguson Toby (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/13/2024
6:03 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
3:00 PM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
3:30 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:32 PM | PFREUNDSCHUH PETER P. (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:34 PM | Sandrock Alfred (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
2:13 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
2:16 PM | Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
2:18 PM | PFREUNDSCHUH PETER P. (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
2:20 PM | Sandrock Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
2:11 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
1:35 PM | ARMISTICE CAPITAL, LLC (Filed by)
Voyager Therapeutics (Subject)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Voyager Therapeutics (Subject)
| Form SC 13G | |
01/19/2024
3:32 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:34 PM | Swartz Robin (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:20 PM | Voyager Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/17/2024
2:21 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
2:33 PM | Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:49 PM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
4:20 PM | Voyager Therapeutics (Filer)
| Form 424B5 | |
01/02/2024
6:05 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
6:04 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
3:41 PM | PFREUNDSCHUH PETER P. (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
3:24 PM | Fahey Sandell Jacquelyn (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:44 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
12:57 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2023
3:18 PM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:00 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:15 AM | Voyager Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/11/2023
3:46 PM | Fahey Sandell Jacquelyn (Reporting)
Voyager Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/11/2023
3:46 PM | Fahey Sandell Jacquelyn (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
3:42 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
7:04 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
10:45 AM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2023
3:32 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
06/30/2023
9:31 AM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
3:37 PM | Colon Grace (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:38 PM | Higgins Michael J (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:39 PM | Onyia Jude (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:40 PM | Vitale Nancy (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:40 PM | MACKEY CATHERINE J (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:41 PM | PIERCE GLENN (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:30 PM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
3:34 PM | Hyman Steven (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:35 PM | SCANGOS GEORGE A (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:36 PM | GERAGHTY JAMES A (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
4:15 PM | SCANGOS GEORGE A (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2023
6:30 AM | Voyager Therapeutics (Filer)
| Form DEFA14A | |
05/09/2023
6:16 AM | Voyager Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
6:03 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2023
6:05 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/27/2023
3:30 PM | Voyager Therapeutics (Filer)
| Form ARS | |
04/27/2023
7:00 AM | Voyager Therapeutics (Filer)
| Form DEF 14A | |
04/27/2023
7:01 AM | Voyager Therapeutics (Filer)
| Form DEFA14A | |
